COVID-19 has spurred long-lasting innovation, says expert

December 25, 2020 | Gareth Macdonald

Biopharma must learn from COVID-19 and make sure it has capacity to respond to future pandemics, according to biobanking firm GoodCell.

Share:

Share on facebook
Share on twitter
Share on linkedin
Share on email